Drug intelligence / Profile preview

Nile tilapia skin xenograft

Development stage
Phase 2
Lead developer
Universidade Federal do Ceará
Administration
Topical
01

Overview

Nile tilapia skin (*Oreochromis niloticus*) is a biological xenograft developed by the Drug Research and Development Center (NPDM) at the Federal University of Ceará (UFC) in Brazil for the treatment of burns. It functions as an occlusive biological dressing and temporary skin substitute. The processed skin is characterized by high levels of type I collagen and a morphological structure similar to human skin, which facilitates adherence to the wound bed, provides a protective barrier, and promotes healing. Clinical trials in both pediatric and adult populations have shown that it reduces healing time, pain intensity, and the frequency of dressing changes compared to conventional silver sulfadiazine treatment. It represents an innovative, low-cost alternative for burn wound management, particularly relevant for low- and middle-income countries.

Other names
Nile tilapia skinOreochromis niloticus skintilapia skin biological dressing
02

Targets

COL1 (Collagen type I)

Beyond the preview

Go deeper on Nile tilapia skin xenograft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nile tilapia skin xenograft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call